The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research

European Journal of Biochemistry

Volumn 267, Issue 1, 2000, Pages 61-67

  Grover, Phulwinder K ^a   Dogra, Satish C ^b   Davidson, Benjamin P ^b   Stapleton, Alan M F ^a   Ryall, Rosemary L ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

Calcium oxalate; Macromolecules; Prothrombin; Urinary prothrombin fragment 1; Urolithiasis

Indexed keywords

CALCIUM OXALATE; PROTHROMBIN;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MACROMOLECULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; SEQUENCE ANALYSIS; UROLITHIASIS;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; KIDNEY; LIVER; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTHROMBIN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; THROMBIN; URINARY CALCULI;

EID: 0033958422     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.00954.x     Document Type: Article

References (35)

1. 1. Boyce, W.H. (1968) Organic matrix of human urinary concretions. Amer. J. Med. 45, 673-683.
2. 2. Ryall, R.L. (1997) Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J. Urol. 15, 155-164.
3. 3. Morse, R.M. & Resnick, M.I. (1988) A new approach to the study of urinary macromolecules as participant in calcium oxalate crystallization. J. Urol. 39, 869-873.
4. 4. Doyle, I.R., Ryall, R.L. & Marshall, V.R. (1991) Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin. Chem. 37, 1589-1594.
5. 5. Grover, P.K., Moritz, R.L., Simpson, R.J. & Ryall, R.L. (1998) Inhibition of growth and aggregation of calcium oxalate crystals in vitro: a comparison of four human proteins. Eur. J. Biochem. 253, 637-644.
6. 6. Ryall, R.L., Grover, P.K., Stapleton, A.M.E, Barrell, D.K., Tang, Y., Moritz, R.L. & Simpson, R.J. (1995) The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin. Sci. 89, 533-541.
7. 7. Stapleton, A.M.F., Dawson, C.J., Grover, P.K., Hohmann, A., Comacchio, R., Boswarva, V., Tang, Y. & Ryall, R.L. (1996) Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix, Kidney Int. 49, 880-888.
8. 8. Stapleton, A.M.F., Seymour, A.E., Brennan, J.S., Doyle, I.R., Marshall, V.R. & Ryall, R.L. (1993) Immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int. 44, 817-824.
9. 9. Stapleton, A.M.F., Timme, T.L. & Ryall, R.L. (1998) Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease. Br. J. Urol. 81, 666-672.
10. 10. Khan, S.R. & Hackett, R.L. (1985) Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? Scan. Electron Microscopy 2, 759-774.
11. 11. Khan, S.R. (1995) Mechanisms involved in calcium oxalate nephrolithiasis based on studies in an animal world. Ital. J. Mineral Electrolyte Metab. 9, 3-9.
12. 12. Khan, S.R. (1997) Animal models of kidney stone formation: an analysis. World J. Urol. 15, 236-243.
13. 13. Dihanich, M. & Monard, D. (1990) cDNA sequence of rat prothrombin. Nucleic Acids Res. 18, 4251.
14. 14. Fort, Ph., Marty, L., Piechaczyk, M., El-Sabrouty, S., Dani, Ch., Jeanteur, Ph. & Blanchard, J.M. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13, 1431-1442.
15. 15. Willfinger, W.W., Mackey, K. & Chomczynski, P. (1997) The effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 22, 474-481.
16. 16. Degen, S.J.F. (1992) The prothrombin gene and its liver-specific expression. Semin. Thromb. Haem. 18, 230-242.
17. 17. Jamison, C.S. & Degen, S.J.F. (1991) Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochem. Biophys. Acta 1088, 208-216.
18. 18. Sekiya, F., Usui, H., Inoue, K., Fukudome, K. & Morita, T. (1994) Activation of prothrombin by a novel-membrane-associated protease, J. Biol. Chem. 269, 32441-32445.
19. 19. Suzuki, K., Suga, K., Miyazawa, K. & Tsugawa, R. (1997) Where is the origin of crystal matrix protein? Expression of prothrombin mRNA in human and rat kidney. Br. J. Urol. 80 (Suppl. 2), 322.
20. 20. Dihanich, M., Kaser, M., Reinhard, F., Cunningham, D. & Monard, D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581.
21. 21. Gurwitz, D. & Cunningham, D.D. (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl Acad. Sci. USA 85, 3440-3444.
22. 22. Jalink, K. & Moolenaar, W.H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messages. J. Cell. Biol. 118, 411-419.
23. 23. Baker, J.B., Low, D.A., Simmer, R.L. & Cunningham, D.D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37-45.
24. 24. Wagner, S.L., Geddes, J.W., Cotman, C.W., Lau, A.L., Gurwitz, D., Isackson, P.J. & Cunningham, D.D. (1989) Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 8284-8288.
25. 25. Tapparelli, C., Metternich, R. & Cook, N.S. (1993) Structure and function of thrombin receptors. Trends Pharmacol. Sci. 14, 426-428.
26. 26. Bezeaud, A. & Guillin, M.-C. (1984) Quantitation of prothrombin activation products in human urine. Br. J. Haematol. 58, 597-606.
27. 27. Hauschka, P.V., Friedman, P.A., Traverso, H.P. & Gallop, P.M. (1976) Vitamin K-dependent γ-carboxyglutamic acid formation by kidney microsomes in vitro. Biochem. Biophys. Res. Commun. 71, 1207-1213.
28. 28. Buchtal, S.D. & Bell, R.G. (1983) Vitamin K-dependent carboxylation of glutamate residues to γ-carboxyglutamate in microsomes from spleen and testes: comparison with liver. Lung and Kidney 22, 1077-1082.
29. 29. Friedman, P.A., Mitch, W.E. & Silva, P. (1982) Localization of renal vitamin K-dependent γ-glutamyl carboxylase to tubules cells. J. Biol. Chem. 257, 11037-11040.
30. 30. Hazelett, S.E. & Preusch, PC. (1988) Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase. Clin. Pharmacol. 37, 929-934.
31. 31. Hauschka, P.V., Lian, J.B. & Gallop, P.M. (1978) Vitamin K and mineralization. Trends Biochem. Sci. 3, 75-78.
32. 32. Ono, M., Ohta, H., Ohhira, M., Sekiya, C. & Namiki, M. (1990) Measurements of immunoreactive prothrombin, des-γ-carboxy prothrombin and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma. Amer. J. Gastmenterol. 85, 1149-1154.
33. 33. Weitz, I.C. & Liebman, H.A. (1993) Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 18, 990-997.
34. 34. Stapleton, A.M.F. & Ryall, R.L. (1995) Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin. Br. J. Urol. 75, 712-719.
35. 35. Stapleton, A.M.F. (1995) Crystal matrix protein and urolithiasis: getting blood out of a stone. PhD Thesis, The Flinders University of South Australia, Adelaide.